Walgreens (WBA) was the worst-performing stock in the S&P 500 (^GSPC) in 2024. The stock surged though after the ...

Equity bulls were hoping for a payrolls number that was not too hot and not too cold. However, a notably ...

This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

Stockhead’s Fraser Palamara sits down with Island Pharmaceuticals (ASX:ILA)  CEO and managing director David Foster to get the short end of the long story on the company’s latest news.

Investors can check the allotment status through two primary methods: the BSE website or the KFin Technologies portal.

For the last six to seven weeks, Gland Pharma stock has witnessed a series of consolidations as prices fluctuated in the range of 1700-1850 levels. It broke out from the said range last week. Traders ...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

The stock market journey in 2024 was a rollercoaster, with an exceptional rally in the first half, followed by a sharp correction in the latter half. Despite the volatility, the Nifty closed the year ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

GBP/USD preserves its recovery momentum and trades above 1.2400 heading into the American session on Friday. A broad pullback in the US Dollar allows the pair to find some respite after having lost ...

NRx Pharmaceuticals shares gained after the company said it would buy California psychiatry clinic Kadima Neuropsychiatry Institute. The stock rose Thursday to $2.92, reaching a six-month high. Shares ...

What are the key stocks to watch in 2025? Arpit Beriwal, Analyst - Derivatives, Wealth Management, Motilal Oswal Financial ...